NCT00232427已完成不适用
Optimized Therapy of Decompensated Liver Cirrhosis by Hemodynamic Monitoring Using the PiCCO System
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- Survival
研究概览
简要总结
Prospective comparison of standard therapy in liver cirrhosis versus standard therapy plus intensified hemodynamic monitoring using the PiCCO system.
详细描述
Patients presenting with advanced liver cirrhosis will receive either standard treatment or standard treatment plus hemodynamic monitoring with the PiCCO device. Fluids and vasoacitve drugs will be administered according to the measurements over a period of 5 days.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Liver cirrhosis Child-Pugh-Score > 7
- •Ascites > 500 ml
排除标准
- •Coronary heart disease
- •Apoplexia < 6 months ago
- •Vasculitis
- •Thrombosis
- •Arterial occlusive disease > stadium II
结局指标
主要结局
Survival
次要结局
- Renal complications
- Length of intensive care
- Change in APACHE II
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
2 期
Clinical Trial of Umbilical Cord Mesenchymal Stem Cell Transfusion in Decompensated Liver CirrhosisDecompensated Liver CirrhosisNCT03529136Shandong Qilu Stem Cells Engineering Co., Ltd.252
招募中
2 期
Effect of Mesenchymal Stem Cells-derived Exosomes in Decompensated Liver CirrhosisDecompensated Liver CirrhosisNCT05871463Research Institute for Gastroenterology and Liver Diseases (RIGLD)15
已完成
1 期
Autologous Bone Marrow Derived Stem Cells in Decompensate Cirrhotic PatientsLiver CirrhosisNCT01120925Royan Institute30
已完成
3 期
Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116)Hepatitis C, ChronicLiver CirrhosisNCT00687219Merck Sharp & Dohme LLC102
已完成
1 期
Umbilical Cord Mesenchymal Stem Cells for Patients With Liver CirrhosisLiver CirrhosisNCT01220492Beijing 302 Hospital266